The European & Developing Countries Clinical Trials Partnership (EDCTP) funds clinical research to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.
EDCTP is hiring!
“Join the EDCTP Calls & Grants team! We’re looking for a Project Officer (one year) and would like to receive your application as soon as possible!” Pauline Beattie, EDCTP Operations manager
Overview of selected EDCTP-funded clinical studies for medical interventions against poverty-related infectious diseases, 2003-2018.
PredART trial shows TB-IRIS can be prevented in patients with HIV-TB co-infection
The results of the PredART clinical trial co-funded by EDCTP were published in the New England Journal of Medicine on 14 November 2018. Prof. Graeme Meintjes (University of Cape Town) and his team showed that a moderate dose of prednisone…
EDCTP and Wellcome Trust organise session at ASTMH 2018
EDCTP and the Wellcome Trust organised a session on controlled Human Infection Studies in low- and middle-income countries as a contribution to the ASTMH 2018 programme. The symposium (session 169) takes place on 1 November from 08:00-09:45. The annual meeting…